Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms
Open accessAbstract
The reversible fatty acid amide hydrolase (FAAH) inhibitor OL135 reverses mechanical allodynia in the spinal nerve ligation (SNL) and mild thermal injury (MTI) models in the rat. The purpose of this study was to investigate the role of the cannabinoid and opioid systems in mediating this analgesic effect. Elevated brain concentrations of anandamide (350 pmol g−1 of tissue vs 60 pmol g−1 in vehicle‐treated controls) were found in brains of rats given OL135 (20 mg kg−1) i.p. 15 min prior to 20 mg kg−1 i.p. anandamide. Predosing rats with OL135 (2–60 mg kg−1 i.p.) 30 min before administration of an irreversible FAAH inhibitor (URB597: 0.3 mg kg−1 intracardiac) was found to protect brain FAAH from irreversible inactivation. The level of enzyme protection was correlated with the OL135 concentrations in the same brains. OL135 (100 mg kg−1 i.p.) reduced by 50% of the maximum possible efficacy (MPE) mechanical allodynia induced by MTI in FAAH+/+mice (von Frey filament measurement) 30 min after dosing, but was without effect in FAAH−/− mice. OL135 given i.p. resulted in a dose‐responsive reversal of mechanical allodynia in both MTI and SNL models in the rat with an ED50 between 6 and 9 mg kg−1. The plasma concentration at the ED50 in both models was 0.7 μM (240 ng ml−1). In the rat SNL model, coadministration of the selective CB2 receptor antagonist SR144528 (5 mg kg−1 i.p.), with 20 mg kg−1 OL135 blocked the OL135‐induced reversal of mechanical allodynia, but the selective CB1 antagonist SR141716A (5 mg kg−1 i.p.) was without effect. In the rat MTI model neither SR141716A or SR144528 (both at 5 mg kg−1 i.p.), or a combination of both antagonists coadministered with OL135 (20 mg kg−1) blocked reversal of mechanical allodynia assessed 30 min after dosing. In both the MTI model and SNL models in rats, naloxone (1 mg kg−1, i.p. 30 min after OL135) reversed the analgesia (to 15% of control levels in the MTI model, to zero in the SNL) produced by OL135. British Journal of Pharmacology (2006) 148, 102–113. doi: 10.1038/sj.bjp.0706699
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
OL135, a compound that accesses the CNS and inhibits FAAH, suppressed mechanical allodynia in a CB2-dependent manner.
“Additionally, OL135, a compound that accesses the CNS and inhibits FAAH, suppressed mechanical allodynia in a CB2-dependent manner.91”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
1 retracted
Gabapentin for acute and chronic pain
Wiffen, P. J., McQuay, H. J., Edwards, J. E., & Moore, R. A. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005452 · Cited by 247 · see citing works
RetractedQuantitative assessment of tactile allodynia in the rat paw
Chaplan, S. R., Bach, F. W., Pogrel, J. W., Chung, J. M., & Yaksh, T. L. (1994) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(94)90144-9 · Cited by 7,740 · see citing works
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633 · see citing works
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · see citing works
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011 · see citing works
Ho Kim, S., & Mo Chung, J. (1992) · Pain · doi:10.1016/0304-3959(92)90041-9 · Cited by 3,069 · see citing works
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586 · see citing works
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Marzo, V. D., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,585 · see citing works
Cravatt, B. F., Demarest, K., Patricelli, M. P., Bracey, M. H., Giang, D. K., Martin, B. R., & Lichtman, A. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161191698 · Cited by 1,310 · see citing works
Control of pain initiation by endogenous cannabinoids
Calignano, A., Rana, G. L., Giuffrida, A., & Piomelli, D. (1998) · Nature · doi:10.1038/28393 · Cited by 1,055 · see citing works
Lo Verme, J., Fu, J., Astarita, G., La Rana, G., Russo, R., Calignano, A., & Piomelli, D. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006353 · Cited by 882 · see citing works
Neuropathic pain and spinal microglia: a big problem from molecules in ‘small’ glia
Tsuda, M., Inoue, K., & Salter, M. W. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.12.002 · Cited by 795 · see citing works
Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons
Twitchell, W., Brown, S., & Mackie, K. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.78.1.43 · Cited by 544 · see citing works
Ibrahim, M. M., Porreca, F., Lai, J., Albrecht, P. J., Rice, F. L., Khodorova, A., Davar, G., Makriyannis, A., Vanderah, T. W., Mata, H. P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409888102 · Cited by 521 · see citing works
Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors
Richardson, J. D., Kilo, S., & Hargreaves, K. (1998) · Pain · doi:10.1016/s0304-3959(97)00213-3 · Cited by 498 · see citing works
Ibrahim, M. M., Deng, H., Zvonok, A., Cockayne, D. A., Kwan, J., Mata, H. P., Vanderah, T. W., Lai, J., Porreca, F., Makriyannis, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834309100 · Cited by 491 · see citing works
Puig, S., & Sorkin, L. S. (1996) · Pain · doi:10.1016/0304-3959(95)00121-2 · Cited by 473 · see citing works
Molecular characterization of human and mouse fatty acid amide hydrolases
Giang, D. K., & Cravatt, B. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2238 · Cited by 429 · see citing works
Fegley, D., Gaetani, S., Duranti, A., Tontini, A., Mor, M., Tarzia, G., & Piomelli, D. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078980 · Cited by 427 · see citing works
Zhang, J., Hoffert, C., Vu, H. K., Groblewski, T., Ahmad, S., & O'Donnell, D. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02704.x · Cited by 419 · see citing works
The neurobiology and evolution of cannabinoid signalling
Elphick, M. R., & Egertová, M. (2001) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2000.0787 · Cited by 416 · see citing works
CB2 cannabinoid receptor-mediated peripheral antinociception
Malan, P. T., Ibrahim, M. M., Deng, H., Liu, Q., Mata, H. P., Vanderah, T., Porreca, F., & Makriyannis, A. (2001) · Pain · doi:10.1016/s0304-3959(01)00321-9 · Cited by 391 · see citing works
Endocannabinoid signaling system and brain reward: emphasis on dopamine
GARDNER, E. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.032 · Cited by 387 · see citing works
Mackie, K., Devane, W. A., & Hille, B. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13215-x · Cited by 365 · see citing works
Jaggar, S., Hasnie, F. S., Sellaturay, S., & Rice, A. S. C. (1998) · Pain · doi:10.1016/s0304-3959(98)00041-4 · Cited by 351 · see citing works
Naturally occurring antinociceptive substances from plants
Calixto, J. Β., Beirith, A., Ferreira, J., Santos, A. R. S., Filho, V. C., & Yunes, R. A. (2000) · Phytotherapy Research · doi:10.1002/1099-1573(200009)14:6 · Cited by 340 · see citing works
Núñez, E., Benito, C., Pazos, M. R., Barbáchano, A., Fajardo, O., González, S. R., Tolón, R. M., & Romero, J. (2004) · Synapse · doi:10.1002/syn.20050 · Cited by 334 · see citing works
Lichtman, A. H., Leung, D., Shelton, C. C., Saghatelian, A., Hardouin, C., Boger, D. L., & Cravatt, B. F. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.069401 · Cited by 329 · see citing works
Biosynthesis of an Endogenous Cannabinoid Precursor in Neurons and its Control by Calcium and cAMP
Cadas, H., Gaillet, S., Beltramo, M., Venance, L., & Piomelli, D. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-12-03934.1996 · Cited by 318 · see citing works
Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons
Ahluwalia, J. P., Urbán, L., Capogna, M., Bevan, S., & Nagy, I. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00389-4 · Cited by 302 · see citing works
Lichtman, A. H., Shelton, C. C., Advani, T., & Cravatt, B. F. (2004) · Pain · doi:10.1016/j.pain.2004.01.022 · Cited by 301 · see citing works
The Palmitoylethanolamide Family: A New Class of Anti-Inflammatory Agents ?
Lambert, D. M., Vandevoorde, S., Jonsson, K., & Fowler, C. J. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023370707 · Cited by 300 · see citing works
Mor, M., Rivara, S., Lodola, A., Plazzi, P. V., Tarzia, G., Duranti, A., Tontini, A., Piersanti, G., Kathuria, S., & Piomelli, D. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031140x · Cited by 276 · see citing works
Hua, X., Svensson, C. I., Matsui, T., Fitzsimmons, B., Yaksh, T. L., & Webb, M. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04451.x · Cited by 248 · see citing works
Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide
Calignano, A., Rana, G. L., & Piomelli, D. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00988-8 · Cited by 241 · see citing works
Marzo, V. D., PETROCELLIS, L. D., Fezza, F., Ligresti, A., & Bisogno, T. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0349 · Cited by 238 · see citing works
Ossipov, M. H., Bian, D., Malan, P. T., Lai, J. Y., & Porreca, F. (1999) · Pain · doi:10.1016/s0304-3959(98)00187-0 · Cited by 218 · see citing works
Barann, M., Molderings, G. J., Brüss, M., Bönisch, H., Urban, B. W., & Göthert, M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704829 · Cited by 215 · see citing works
Dual Effects of Anandamide on NMDA Receptor‐Mediated Responses and Neurotransmission
Hampson, A. J., Bornheim, L. M., Scanziani, M., Yost, C. S., Gray, A. T., Hansen, B. M., Leonoudakis, D., & Bickler, P. E. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70020671.x · Cited by 209 · see citing works
Sugiura, T., Kondo, S., Sukagawa, A., Tonegawa, T., Nakane, S., Yamashita, A., & Waku, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0020 · Cited by 195 · see citing works
Guo, J., & Ikeda, S. R. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.665 · Cited by 190 · see citing works
Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons
Fan, P. (1995) · Journal of Neurophysiology · doi:10.1152/jn.1995.73.2.907 · Cited by 187 · see citing works
Ahluwalia, J., Urbán, L., Bevan, S., & Nagy, I. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02703.x · Cited by 181 · see citing works
Holt, S., Comelli, F., Costa, B., & Fowler, C. J. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706348 · Cited by 168 · see citing works
Spinal cannabinoids are anti-allodynic in rats with persistent inflammation
Martin, W. J., Loo, C. M., & Basbaum, A. I. (1999) · Pain · doi:10.1016/s0304-3959(99)00045-7 · Cited by 162 · see citing works
The Biodisposition and Metabolism of Anandamide in Mice
Willoughby, K. A., Moore, S. F., Martin, B. R., & Ellis, E. F. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36812-0 · Cited by 159 · see citing works
Expression of CB2 cannabinoid receptor mRNA in adult rat retina
Lu, Q., Straiker, A. J., Lu, Q., & Maguire, G. (2000) · Visual Neuroscience · doi:10.1017/s0952523800171093 · Cited by 136 · see citing works
Scott, D. A., Wright, C. E., & Angus, J. A. (2004) · Pain · doi:10.1016/j.pain.2004.01.020 · Cited by 128 · see citing works
Hohmann, A. G., Farthing, J. N., Zvonok, A. M., & Makriyannis, A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060079 · Cited by 123 · see citing works
Bisogno, T., Petrocellis, L., & Marzo, V. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023395655 · Cited by 112 · cited 1× · see citing works
“FAAH metabolises at least two other fatty acid amides, palmitoylethanolamine (PEA) and oleamide, and PEA has both analgesic and anti-inflammatory effects (Bisogno et al., 2002; Lambert et al., 2002).”
BackgroundFranklin, A., & Stella, N. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)02074-0 · Cited by 111 · see citing works
Leung, D., Du, W., Hardouin, C., Cheng, H. W., Hwang, I., Cravatt, B. F., & Boger, D. L. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.12.085 · Cited by 106 · see citing works
Inhibition of pain responses by activation of CB2 cannabinoid receptors
Malan, T. P., Ibrahim, M. M., Vanderah, T. W., Makriyannis, A., & Porreca, F. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00155-x · Cited by 99 · see citing works
The good and the bad effects of (−) trans-delta-9-tetrahydrocannabinol (Δ9-THC) on humans
Carlini, E. A. (2004) · Toxicon · doi:10.1016/j.toxicon.2004.05.009 · Cited by 98 · see citing works
Selective Cannabinoid CB1Receptor Activation Inhibits Spinal Nociceptive Transmission In Vivo
Kelly, S., & Chapman, V. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.6.3061 · Cited by 84 · see citing works
Drew, L., Harris, J. E., Millns, P. J., Kendall, D. A., & Chapman, V. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00101.x · Cited by 82 · see citing works
Roberts, L. A., Christie, M. J., & Connor, M. A. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704904 · Cited by 79 · see citing works
Monhemius, R., Azami, J., Green, D. L., & Roberts, M. H. T. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02605-1 · Cited by 64 · see citing works
A novel model of primary and secondary hyperalgesia after mild thermal injury in the rat
Nozaki‐Taguchi, N., & Yaksh, T. L. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00648-x · Cited by 62 · see citing works
Antisense oligodeoxynucleotide treatment to the brain cannabinoid receptor inhibits antinociception
Edsall, S. A., Knapp, R. J., Vanderah, T. W., Roeske, W. R., Consroe, P. F., & Yamamura, H. I. (1996) · Neuroreport · doi:10.1097/00001756-199601310-00052 · Cited by 43 · see citing works
A high-throughput-compatible assay for determining the activity of fatty acid amide hydrolase
Wilson, S. J., Lovenberg, T. W., & Barbier, A. (2003) · Analytical Biochemistry · doi:10.1016/s0003-2697(03)00217-3 · Cited by 31 · see citing works
Gourlay, D. L. (2005) · Pain Research and Management · doi:10.1155/2005/512653 · Cited by 17 · see citing works
Lee, E., Sim, J.-Y., Park, J. Y., Hwang, J., Park, P.-H., & Han, S. (2002) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03020492 · Cited by 6 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- IBRAHIM, M.M., DENG, H., ZVONOK, A., COCKAYNE, D.A., KWAN, J., MATA, H.P., VANDERAH, T.W., LAI, J., PORRECA, F., MAKRIYANNIS, A. & MALAN Jr, T.P. (2003). Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuro- pathic pain: pain inhibition by receptors not present in the CNS. Proc. Natl. Acad. Sci. U.S.A., 100, 10529-10533.
Cited by
Sorted by citations
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077 · see citing works
Targeting the endocannabinoid system: to enhance or reduce?
Marzo, V. D. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2553 · Cited by 798 · see citing works
Enzymatic pathways that regulate endocannabinoid signaling in the nervous system
Ahn, K., McKinney, M. K., & Cravatt, B. F. (2008) · Chemical Reviews · doi:10.1021/cr0782067 · Cited by 529 · see citing works
Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain
Ahn, K., Johnson, D. S., Mileni, M., Beidler, D., Long, J. Z., McKinney, M. K., Weerapana, E., Sadagopan, N., Liimatta, M., Smith, S. E., et al. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.02.013 · Cited by 439 · see citing works
Huggins, J. P., Smart, T. S., Langman, S., Taylor, L., & Young, T. (2012) · Pain · doi:10.1016/j.pain.2012.04.020 · Cited by 375 · see citing works
Blockade of Endocannabinoid-Degrading Enzymes Attenuates Neuropathic Pain
Kinsey, S. G., Long, J. Z., O’Neal, S. T., Abdullah, R. A., Poklis, J. L., Boger, D. L., Cravatt, B. F., & Lichtman, A. H. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155465 · Cited by 330 · see citing works
Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside
Rahn, E. J., & Hohmann, A. G. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.08.002 · Cited by 305 · see citing works
The cannabinoid system and pain
Woodhams, S. G., Chapman, V., Finn, D. P., Hohmann, A. G., & Neugebauer, V. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.015 · Cited by 272 · see citing works
Fraguas‐Sánchez, A. I., & Torres‐Suárez, A. I. (2018) · Drugs · doi:10.1007/s40265-018-0996-1 · Cited by 271 · see citing works
Ahn, K., Smith, S. E., Liimatta, M. B., Beidler, D. R., Sadagopan, N., Dudley, D. T., Young, T., Wren, P. B., Zhang, Y., Swaney, S. M., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.180257 · Cited by 229 · see citing works
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain
Anand, P., Whiteside, G. T., Fowler, C. J., & Hohmann, A. G. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.12.003 · Cited by 217 · see citing works
The Role of the Endocannabinoid System in Pain
Woodhams, S. G., Sagar, D. R., Burston, J. J., & Chapman, V. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-46450-2_7 · Cited by 205 · see citing works
Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain
Roques, B. P., Fournié‐Zaluski, M., & Wurm, M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3673 · Cited by 193 · see citing works
Ahn, K., Johnson, D. S., & Cravatt, B. F. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440903018857 · Cited by 198 · see citing works
Discovery and Development of Fatty Acid Amide Hydrolase (FAAH) Inhibitors
Seierstad, M. J., & Breitenbucher, J. G. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800311k · Cited by 179 · see citing works
Targeting Fatty Acid Amide Hydrolase (FAAH) to Treat Pain and Inflammation
Schlosburg, J. E., Kinsey, S. G., & Lichtman, A. H. (2009) · The AAPS Journal · doi:10.1208/s12248-008-9075-y · Cited by 165 · see citing works
Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain
Jhaveri, M. D., Richardson, D., Kendall, D. A., Barrett, D. A., & Chapman, V. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3326-06.2006 · Cited by 159 · see citing works
Structure-guided inhibitor design for human FAAH by interspecies active site conversion
Mileni, M., Johnson, D. S., Wang, Z., Everdeen, D. S., Liimatta, M. B., Pabst, B. A., Bhattacharya, K., Nugent, R. A., Kamtekar, S., Cravatt, B. F., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806121105 · Cited by 154 · see citing works
Wang, X., Sarris, K., Kage, K., Zhang, D., Brown, S. P., Kolasa, T., Surowy, C. S., El-Kouhen, O. F., Muchmore, S. W., Brioni, J. D., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801042a · Cited by 153 · see citing works
Hegde, V. L., Hegde, S., Cravatt, B. F., Hofseth, L. J., Nagarkatti, M., & Nagarkatti, P. S. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.047035 · Cited by 147 · see citing works
Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain
Jhaveri, M. D., Richardson, D. S., & Chapman, V. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707433 · Cited by 145 · see citing works
The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH)
Otrubova, K., Ezzili, C., & Boger, D. L. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.06.096 · Cited by 130 · see citing works
Ignatowska‐Jankowska, B. M., Ghosh, S., Crowe, M. S., Kinsey, S. G., Niphakis, M. J., Abdullah, R. A., Tao, Q., O' Neal, S. T., Walentiny, D. M., Wiley, J. L., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12298 · Cited by 128 · see citing works
Ghosh, S., Wise, L. E., Chen, Y., Gujjar, R., Mahadevan, A., Cravatt, B. F., & Lichtman, A. H. (2013) · Life Sciences · doi:10.1016/j.lfs.2012.06.020 · Cited by 127 · see citing works
Li, G. L., Winter, H. R., Arends, R., Jay, G. W., Le, V., Young, T., & Huggins, J. P. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04137.x · Cited by 125 · see citing works
Jhaveri, M. D., Richardson, D. S., Robinson, I., Garle, M. J., Patel, A., Sun, Y., Sagar, D. R., Bennett, A. J., Alexander, S. P. H., Kendall, D. A., et al. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.04.018 · Cited by 122 · see citing works
Kinsey, S. G., Long, J. Z., Cravatt, B. F., & Lichtman, A. H. (2010) · The Journal of Pain · doi:10.1016/j.jpain.2010.04.001 · Cited by 118 · see citing works
Booker, L., Kinsey, S. G., Abdullah, R. A., Blankman, J. L., Long, J. Z., Ezzili, C., Boger, D. L., Cravatt, B. F., & Lichtman, A. H. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01445.x · Cited by 116 · see citing works
Tuo, W., Leleu‐Chavain, N., Spencer, J., Sansook, S., Millet, R., & Chavatte, P. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00538 · Cited by 114 · see citing works
Naidu, P. S., Booker, L., Cravatt, B. F., & Lichtman, A. H. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143487 · Cited by 114 · see citing works
Cannabinoids and Multiple Sclerosis
Pertwee, R. G. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0005-2 · Cited by 113 · see citing works
Mileni, M., Kamtekar, S., Wood, D. C., Benson, T. E., Cravatt, B. F., & Stevens, R. C. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.05.034 · Cited by 108 · see citing works
Enhanced endocannabinoid tone as a potential target of pharmacotherapy
Toczek, M., & Malinowska, B. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.04.054 · Cited by 104 · see citing works
Zhang, D., Saraf, A., Kolasa, T., Bhatia, P., Zheng, G. Z., Patel, M., Lannoye, G. S., Richardson, P., Stewart, A., Rogers, J. C., et al. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.11.009 · Cited by 99 · see citing works
Hwang, J., Adamson, C. L., Butler, D., Janero, D. R., Makriyannis, A., & Bahr, B. A. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.06.003 · Cited by 97 · see citing works
Garfunkle, J., Ezzili, C., Rayl, T. J., Hochstatter, D. G., Hwang, I., & Boger, D. L. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800136b · Cited by 98 · see citing works
Dynamic Regulation of the Endocannabinoid System: Implications for Analgesia
Sagar, D. R., Gaw, A. G., Okine, B. N., Woodhams, S. G., Wong, A., Kendall, D. A., & Chapman, V. (2009) · Molecular Pain · doi:10.1186/1744-8069-5-59 · Cited by 96 · see citing works
Endogenous opiates and behavior: 2006
Bodnar, R. J. (2007) · Peptides · doi:10.1016/j.peptides.2007.09.002 · Cited by 91 · see citing works
Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase
Keith, J. M., Apodaca, R. L., Xiao, W., Seierstad, M. J., Pattabiraman, K., Wu, J., Webb, M., Karbarz, M. J., Brown, S. M., Wilson, S. M. B., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.081 · Cited by 90 · see citing works
Sagar, D. R., Kendall, D. A., & Chapman, V. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.335 · Cited by 88 · see citing works
Mileni, M., Garfunkle, J., DeMartino, J. K., Cravatt, B. F., Boger, D. L., & Stevens, R. C. (2009) · Journal of the American Chemical Society · doi:10.1021/ja902694n · Cited by 89 · see citing works
FAAH inhibitors in the limelight, but regrettably
Mallet, C., Dubray, C., & Dualé, C. (2016) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cp202687 · Cited by 87 · see citing works
The Difference a Single Atom Can Make: Synthesis and Design at the Chemistry–Biology Interface
Boger, D. L. (2017) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.7b02088 · Cited by 80 · see citing works
Nadal, X., La Porta, C., Andreea Bura, S., & Maldonado, R. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.077 · Cited by 76 · see citing works
Karbarz, M. J., Luo, L., Chang, L., Tham, C.-S., Palmer, J. A., Wilson, S. J., Wennerholm, M. L., Brown, S. M., Scott, B. P., Apodaca, R. L., et al. (2009) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31818c7cbd · Cited by 74 · see citing works
Self-citationLu, G., Zhou, Q., Sun, S.-Q., Leung, K. S., Zhang, H., & Zhao, Z. (2007) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2007.12.008 · Cited by 74 · see citing works
Schuelert, N., Johnson, M. P., Oskins, J. L., Jassal, K., Chambers, M. G., & McDougall, J. J. (2011) · Pain · doi:10.1016/j.pain.2010.11.025 · Cited by 70 · see citing works
Caprioli, A., Coccurello, R., Rapino, C., Serio, S. D., Tommaso, M. D., Vertechy, M., Vacca, V., Battista, N., Pavone, F., Maccarrone, M., et al. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.191403 · Cited by 68 · see citing works
Butler, R. K., Rea, K., Lang, Y., Gavin, A. M., & Finn, D. P. (2008) · Pain · doi:10.1016/j.pain.2008.10.002 · Cited by 68 · see citing works
Wallace, V. C. J., Segerdahl, A. R., Lambert, D. M., Vandevoorde, S., Blackbeard, J., Pheby, T., Hasnie, F., & Rice, A. S. C. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707326 · Cited by 66 · see citing works
A Binding Site for Nonsteroidal Anti-inflammatory Drugs in Fatty Acid Amide Hydrolase
Bertolacci, L., Romeo, E., Veronesi, M., Magotti, P., Albani, C., Dionisi, M., Lambruschini, C., Scarpelli, R., Cavalli, A., Vivo, M. D., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja308733u · Cited by 64 · see citing works
Endocannabinoid system and pain: an introduction
Burston, J. J., & Woodhams, S. G. (2013) · Proceedings of The Nutrition Society · doi:10.1017/s0029665113003650 · Cited by 65 · see citing works
Marco, E. M., & Giovanni Laviola, A. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111408459 · Cited by 65 · see citing works
Latest advances in the discovery of fatty acid amide hydrolase inhibitors
Bisogno, T., & Maccarrone, M. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.780021 · Cited by 65 · see citing works
Discovery of Boronic Acids as Novel and Potent Inhibitors of Fatty Acid Amide Hydrolase
Minkkilä, A., Saario, S. M., Käsnänen, H., Leppänen, J., Poso, A., & Nevalainen, T. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801051t · Cited by 65 · see citing works
Fichna, J., Sałaga, M., Stuart, J. M., Saur, D., Sobczak, M., Zatorski, H., Timmermans, J., Bradshaw, H. B., Ahn, K., & Storr, M. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12272 · Cited by 64 · see citing works
Malek, N., Mrugala, M., Makuch, W., Kolosowska, N., Przewlocka, B., Binkowski, M., Czaja, M., Morera, E., Di Marzo, V., & Starowicz, K. (2015) · Pain · doi:10.1097/j.pain.0000000000000132 · Cited by 63 · see citing works
Lever, I. J., Robinson, M., Cibelli, M., Paule, C. C., Sántha, P., Yee, L., Hunt, S. P., Cravatt, B. F., Elphick, M. R., Nagy, I., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4071-08.2009 · Cited by 63 · see citing works
Bashashati, M., Storr, M., Nikas, S. P., Wood, J., Godlewski, G., Liu, J., Ho, W. ‐. V., Keenan, C. M., Zhang, H., Alapafuja, S. O., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01644.x · Cited by 61 · see citing works
Optimization of α-Ketooxazole Inhibitors of Fatty Acid Amide Hydrolase
Kimball, F. S., Romero, F. A., Ezzili, C., Garfunkle, J., Rayl, T. J., Hochstatter, D. G., Hwang, I., & Boger, D. L. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701210y · Cited by 61 · see citing works
Therapeutic Potential of Endocannabinoid‐Hydrolysing Enzyme Inhibitors
Saario, S. M., & Laitinen, J. T. (2007) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2007.00130.x · Cited by 60 · see citing works
Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system
Starowicz, K., & Przewłocka, B. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0392 · Cited by 57 · see citing works
Fowler, C., Naidu, P., Lichtman, A. H., & Onnis, V. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00029.x · Cited by 57 · see citing works
Fowler, C. J. (2006) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2006.00442.x · Cited by 57 · see citing works
Okine, B. N., Norris, L. M., Woodhams, S. G., Burston, J. J., Patel, A., Alexander, S. P. H., Barrett, D. A., Kendall, D. A., Bennett, A. J., & Chapman, V. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02028.x · Cited by 56 · see citing works
Niphakis, M. J., Johnson, D. S., Ballard, T. E., Stiff, C. M., & Cravatt, B. F. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200089j · Cited by 56 · see citing works
Ghosh, S., Kinsey, S. G., Liu, Q.-S., Hruba, L., McMahon, L. R., Grim, T. W., Merritt, C. R., Wise, L. E., Abdullah, R. A., Selley, D. E., et al. (2015) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.222851 · Cited by 54 · see citing works
Landry, R. P., Martinez, E., DeLeo, J. A., & Romero-Sandoval, E. A. (2012) · Journal of Pain · doi:10.1016/j.jpain.2012.05.013 · Cited by 51 · see citing works
Mileni, M., Garfunkle, J., Ezzili, C., Kimball, F. S., Cravatt, B. F., Stevens, R. C., & Boger, D. L. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9012196 · Cited by 52 · see citing works
Małek, N., & Starowicz, K. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00257 · Cited by 51 · see citing works
Desroches, J., Charron, S., Bouchard, J., & Beaulieu, P. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.10.006 · Cited by 51 · see citing works
Grim, T. W., Ghosh, S., Hsu, K.-L., Cravatt, B. F., Kinsey, S. G., & Lichtman, A. H. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.07.008 · Cited by 50 · see citing works
Pawsey, S., Wood, M., Browne, H. L., Donaldson, K. M., Christie, M. I., & Warrington, S. (2016) · Drugs in R&D · doi:10.1007/s40268-016-0127-y · Cited by 50 · see citing works
Ezzili, C., Mileni, M., McGlinchey, N., Long, J. Z., Kinsey, S. G., Hochstatter, D. G., Stevens, R. C., Lichtman, A. H., Cravatt, B. F., Bilsky, E. J., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101597x · Cited by 49 · see citing works
Identification of potent, noncovalent fatty acid amide hydrolase (FAAH) inhibitors
Gustin, D. J., Ma, Z., Min, X., Li, Y., Hedberg, C., Guimarães, C. R. W., Porter, A. C., Lindström, M., Lester-Zeiner, D., Xu, G., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.02.052 · Cited by 48 · see citing works
Sakın, Y. S., Dogrul, A. B., İlkaya, F., Seyrek, M., Ulaş, Ü. H., Gülşen, M., & Bagci, S. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12563 · Cited by 47 · see citing works
Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase
Thors, L., Burston, J. J., Alter, B. J., McKinney, M., Cravatt, B., Ross, R., Pertwee, R. G., th, R. W. G., Wiley, J. L., & Fowler, C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00716.x · Cited by 46 · see citing works
The Potential of Inhibitors of Endocannabinoid Metabolism for Drug Development: A Critical Review
Fowler, C. J. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_4 · Cited by 45 · see citing works
Osteoarthritic pain: a review of current, theoretical and emerging therapeutics
Read, S., & Dray, A. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.5.619 · Cited by 44 · see citing works
Nasirinezhad, F., Jergová, S., Pearson, J. P., & Sagen, J. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.024 · Cited by 41 · see citing works
Targeted Covalent Enzyme Inhibitors
Noe, M. C., & Gilbert, A. M. (2012) · Annual reports in medicinal chemistry · doi:10.1016/b978-0-12-396492-2.00027-8 · Cited by 39 · see citing works
Roohbakhsh, A., Keshavarz, S., Hasanein, P., Rezvani, M. E., & Moghaddam, A. H. (2009) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2009.00449.x · Cited by 38 · see citing works
Feledziak, M., Michaux, C., Urbach, A., Labar, G., Muccioli, G. G., Lambert, D. M., & Marchand‐Brynaert, J. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9008532 · Cited by 38 · see citing works
DeMartino, J. K., Garfunkle, J., Hochstatter, D. G., Cravatt, B. F., & Boger, D. L. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.06.084 · Cited by 38 · see citing works
Hagenacker, T., Ledwig, D., & Büsselberg, D. (2007) · Cell Calcium · doi:10.1016/j.ceca.2007.05.019 · Cited by 39 · see citing works
Hoyer, F. F., Khoury, M., Slomka, H., Kebschull, M., Lerner, R., Lutz, B., Schött, H.-F., Lütjohann, D., Wojtalla, A., Becker, A., et al. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.11.013 · Cited by 37 · see citing works
Starowicz, K., & Marzo, V. D. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.075 · Cited by 38 · see citing works
Lichtman, A. H., Blankman, J. L., & Cravatt, B. F. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.069427 · Cited by 36 · see citing works
Fluorine nuclear magnetic resonance-based assay in living mammalian cells
Veronesi, M., Giacomina, F., Romeo, E., Castellani, B., Ottonello, G., Lambruschini, C., Garau, G., Scarpelli, R., Bandiera, T., Piomelli, D., et al. (2015) · Analytical Biochemistry · doi:10.1016/j.ab.2015.11.015 · Cited by 36 · see citing works
Mileni, M., Garfunkle, J., Ezzili, C., Cravatt, B. F., Stevens, R. C., & Boger, D. L. (2011) · Journal of the American Chemical Society · doi:10.1021/ja110877y · Cited by 35 · see citing works
α-Ketoheterocycle-Based Inhibitors of Fatty Acid Amide Hydrolase (FAAH)
Otrubova, K., & Boger, D. L. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn2001206 · Cited by 35 · see citing works
Pietra, A. D., Giniatullin, R. A., & Savinainen, J. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031204 · Cited by 35 · see citing works
Supra-spinal FAAH is required for the analgesic action of paracetamol in an inflammatory context
Dalmann, R., Daulhac, L., Antri, M., Eschalier, A., & Mallet, C. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.006 · Cited by 32 · see citing works
Maione, S., Morera, E., Marabese, I., Ligresti, A., Luongo, L., Ortar, G., & Marzo, V. D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.308 · Cited by 33 · see citing works
Otrubova, K., Brown, M. A., McCormick, M. S., Han, G. W., O’Neal, S. T., Cravatt, B. F., Stevens, R. C., Lichtman, A. H., & Boger, D. L. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4014997 · Cited by 32 · see citing works
Su, S., Wu, Y.-F., Lin, Q., Yu, F., & Hai, J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.021 · Cited by 32 · see citing works
Hicks, J. W., Parkes, J., Sadovski, O., Tong, J., Houle, S., Vasdev, N., & Wilson, A. A. (2013) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2013.04.008 · Cited by 32 · see citing works
Slivicki, R. A., Xu, Z., Mali, S. S., & Hohmann, A. G. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.02.002 · Cited by 31 · see citing works
TRPV1–FAAH–COX: The Couples Game in Pain Treatment
Aiello, F., Carullo, G., Badolato, M., & Brizzi, A. (2016) · ChemMedChem · doi:10.1002/cmdc.201600111 · Cited by 30 · see citing works
Pillarisetti, S., Alexander, C. W., & Khanna, I. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.08.002 · Cited by 29 · see citing works
- Authors
- Chang, L., Luo, L., Palmer, J. A., Sutton, S., Wilson, S. J., Barbier, A. J., Breitenbucher, J. G., Chaplan, S. R., & Webb, M.
- Affiliations
- Janssen Research & Development (United States) (US)
- Corresponding author
- Webb, Michael
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2006-05
- Volume
- 148
- Issue
- 1
- Pages
- 102-113
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2614602784
- Cited by
- 155
- References
- 63
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 5 · 2022: 3 · 2021: 3 · 2020: 2 · 2019: 3 · 2018: 2 · 2017: 5 · 2016: 10 · 2015: 8 · 2014: 6 · 2013: 11 · 2012: 13
- FWCI
- 12.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Physiology › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
- Keywords
- fatty acid amide hydrolase inhibition, anandamide, endocannabinoid system, opioid system, mechanical allodynia, burns, spinal nerve ligation, CB2 receptor, CB1 receptor, analgesia, URB597, endocannabinoids, neuropathic pain, inflammatory pain, SR144528
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
